Alteria Capital.
The scale player of Indian venture debt: ₹7,500+ Cr deployed across 220+ startups, a claimed Fund I DPI of ~130% and <0.5% losses, Spinny warrants at 28x, with IFC anchoring its short-duration scheme and Dunzo/BluSmart recoveries left undisclosed.
GW GP Score
Alteria is the InnoVen diaspora at scale: Murali and Hattangdi built India's first VD business there, then out-raised everyone (₹960 Cr → ₹1,800 Cr → ₹1,550 Cr funds, ~300 LPs, half of Fund I re-upping). The product innovation is the twin-scheme structure: classic venture debt plus a sub-18-month Shorter Duration Scheme for working capital that IFC made its first such investment in globally. The claims are strong (Fund I DPI ~130%, <0.5% losses, zero Covid-era losses); the verification is weak: nothing audited, and its two publicly-stressed borrowers (Dunzo shut, BluSmart insolvent) carry no disclosed recovery numbers.
Conditional hold: enough signal to track closely, not enough to underwrite without the next proof point.
Portfolio quality depends on a narrow theme; the right comp is concentration risk, not headline unicorn count.
No named analyst override yet; current view is generated from the scored dossier and should be refreshed when the next primary source lands.
Fund IV / 'India Fund I': distributor listing only; verify existence, size, regulator filings.
SDS final close (~$100M target).
Unverified claims meet visible casualties: Dunzo and BluSmart resolutions, if negative, retroactively reprice the <0.5% story.
Computed from current dossier sources; analyst override pending.
The scale leader with the boldest claims and the thinnest verification: G2 on evidence of franchise and product innovation, Low confidence until Dunzo/BluSmart numbers and Fund IV facts exist.
220+ borrowers incl. Zepto/Ather/Spinny; two shut names in the book
DPI ~130% and 28x-warrant claims: strong if true, none verified
SDS product innovation earned IFC's first global cheque in the segment
₹1,670 Cr/2024; oversubscribed Fund III; Fund IV status murky
Three MPs, InnoVen lineage, managed co-founder transition
Portfolio quality 25% · Exit realisation 30% · Sector positioning 15% · Capital velocity 15% · Franchise stability 15%: see the full GP Score methodology · compare this firm →
Current evidence supports the score, but not enough to move it without a fresh exit, fund close or team signal.
Country Delight liquidity clears with credible OFS/block-sale evidence.
SDS final close (~$100M target).
Fund IV / 'India Fund I': distributor listing only; verify existence, size, regulator filings.
Ask for three numbers nobody has published: Dunzo recovery, BluSmart exposure, and Fund IV's actual terms. The ~130% Fund I DPI claim is diligence-able: make them show the distribution schedule.
Unverified claims meet visible casualties: Dunzo and BluSmart resolutions, if negative, retroactively reprice the <0.5% story.
Fund IV / 'India Fund I': distributor listing only; verify existence, size, regulator filings.
Coverage initiated: inaugural GW GP Score.
Catalyst exposure · latest source pressure
Recent public evidence mapped to this GP. Read this before reading the position table: it is where the score can move next.
Keep the file warm; current events cut both ways or are not yet material enough to move score.
Attribution0 positive catalyst(s), 0 pressure catalyst(s); top driver: monthly refresh only.
The funds
₹4,350-4,500 Cr (~$540M) · ₹7,500+ Cr deployed across 4 tracked vehicles.
| Vehicle | Vintage | Size | Stage | Note |
|---|---|---|---|---|
| Fund III: Venture Debt Scheme | 2024Recovery / IPO window | ₹1,550 Cr | Venture debt | Oversubscribed vs ₹1,000 Cr target; ~100-125 borrowers |
| Fund III: Shorter Duration Scheme | raising | ~$100M target | <18-month credit | IFC $11.95M anchor (invested Feb 2025): its first in the segment globally; final close open |
| Fund II / Fund I | 2021 / 2019Peak frenzy | ₹1,800 Cr / ₹960 Cr | Venture debt | ~300 LPs in Fund II; Premji Foundation, Binny Bansal, IndusInd among early backers |
| Fund IV + India Fund I | unverified | n.d. | Venture debt | Visible only as a wealth-platform distributor listing: no press, size or close found (R) |
Closest booksStride Ventures (4 shared) · InnoVen Capital (3 shared) · Temasek (India) (3 shared)computed · E
Fund analytics · LP underwriting screen
Computed from the public dossier: vehicle cadence, realised exits, mark drift, concentration and franchise stability. All computed signals are GW estimates.
Vehicle cadence is neither freshly restocked nor visibly stale.
Next liquidityCountry Delight · Ultrahuman · Jupiter
2 visible exit events since Jul 2024.
Vehicle cadence is neither freshly restocked nor visibly stale.
5 up / 4 flat / 3 down tracked signals.
No senior departure flagged in key people.
5 up / 4 flat / 3 down
2 events since Jul 2024
Largest tracked active exposure
Higher spread = less balanced franchise
Marked overhangOla Electric · Dunzo · BluSmart: names with negative 12-month mark or momentum signals in the reconstructed book.
Exit-led repricing; entry discipline decisive
Cycle-top entry marks; the vintage still being digested
Elevation and Z47 hold the equity
Blume holds the equity side
3one4 and Z47 on equity
Latest cited source appears to be 2025.
2 visible events tracked.
12 representative positions tracked.
No departure signal structured.
Fund-level DPI/TVPI is usually not public; proxy remains estimated.
Peer median 2 · +0
Peer median 3 · +0
Peer median 74 · +0
Peer median 30 · -13
Peer median 0 · +0
Diligence agenda · how this view can change
The live research question, the proof required, and the source standard. This prevents a GP score from becoming a stale label.
Performance proxy evidence remains low-confidence despite a scored dossier.
Recent · Latest cited source appears to be 2025.
Upgrade the weak fields with dated facts before the next score action: Performance proxy.
Prioritise filings and firm disclosures; mark estimates as GW E until then.
SDS final close (~$100M target).
Country Delight: next public-market or secondary print
Evidence quality · source file health
How hard the public record is beneath this view: source mix, freshness, low-confidence fields and the next source action.
Low-confidence fields: Performance proxy.
5 total sources · 20% primary
Latest cited source appears to be 2025.
FounderThesis: Murali profile: DPI/loss claims (Jul 2025)
Upgrade Performance proxy evidence before changing the score.
Source tiering follows Gravitywell policy: primary = filing/regulator/company disclosure, secondary = reputable media or research, E = Gravitywell estimate. Evidence score is a GW control metric, not an external rating.
The position book
220+ borrowers financed. Exposures below are credit positions.
| Company | Sector | Entered | Entry stage | Status | 12-mo signal | Latest read |
|---|---|---|---|---|---|---|
| Zepto | Consumer & Commerce | 2022 | Venture debt | Unicorn | ▲ | — |
| Spinny | Consumer & Commerce | 2019 | VD + warrants | Unicorn | ▲ | Warrants returned 28x (firm claim): the kicker showcase |
| Ather Energy | EV & Climate | 2021 | Venture debt | Public | ▲ | Listed May 2025 |
| Ola Electric | EV & Climate | 2024 | ₹100 Cr pre-IPO debt | Public | ▼ | — |
| BharatPe | Fintech | 2020 | Venture debt | Unicorn | → | — |
| Rebel Foods | Consumer & Commerce | 2021 | ₹150 Cr w/ InnoVen | Unicorn | → | — |
| Country Delight | Consumer & Commerce | 2024 | ₹270 Cr across tranches | Soonicorn | ▲ | Elevation and Z47 hold the equity |
| Ultrahuman | Healthcare | 2025 | ₹100 Cr debt | Soonicorn | ▲ | Blume holds the equity side |
| OneCard | Fintech | 2021 | Venture debt | Unicorn | → | Z47 on equity |
| Jupiter | Fintech | 2021 | Venture debt | Soonicorn | → | 3one4 and Z47 on equity |
| Dunzo | Consumer & Commerce | 2019 | ~$11M VD + small equity | Shut | ▼ | Shut Jan 2025; Reliance wrote off ₹1,645 Cr equity; Alteria's recovery undisclosed: 2019-20 vintage likely amortised (E) |
| BluSmart | EV & Climate | 2022 | Venture debt | Shut | ▼ | CIRP Jul 2025; exposure and recovery undisclosed |
Representative tracked positions reconstructed from public disclosures: not the full book. 12-mo signal is a GW estimate of mark direction from round/exit prints (E). Ownership stakes are not shown: not reliably public.
Sector exposure · where the book leans
Share of the tracked active book by normalized sector (GW estimate): read against our sector dossiers for crowding.
New cheques · 2025-26
107 deals in 2023, ₹1,670 Cr deployed in 2024, Fund III targeted fully-deployed by Dec 2026: the highest-volume credit desk in the market alongside Stride. The SDS product is the strategic tell: sub-18-month working-capital finance for fintech loan books, consumer inventory and EV OEMs: banking products for companies banks won't touch.
With Trifecta, BlackSoil
Realisation · are LPs getting paid?
The claims are the strongest on the credit desk: Fund I DPI ~130%, <0.5% losses on ₹7,500 Cr, zero Covid losses, and none are audited or SEBI-disclosed. Two shut borrowers (Dunzo, BluSmart) with undisclosed recoveries are exactly the cases where published numbers would convert marketing into credibility.
Borrower listed; debt serviced, warrants in the money.
Borrower shut down. Alteria's ~$11M 2019-20 exposure: recovery never disclosed; secured-creditor priority + short tenors make prior amortisation plausible (E).
Firm-side; would be the desk's best realised figure if verified
Unaudited; pre-dates Dunzo/BluSmart resolutions
~300 LPs; IFC anchored the SDS
No press, size or close: flagged R
Highest-conviction claims, lowest verification on the desk. GW read: the InnoVen pedigree and IFC's SDS anchor argue the book is sound; the refusal to number Dunzo and BluSmart argues the marketing is ahead of the disclosure. E.
What they're doing
Twin-scheme structure: classic VD (12-36mo, ~14% + warrants) plus the SDS (<18mo working capital): a product ladder toward becoming a full credit house.
Scale as moat: largest domestic VD fund family, ₹150-200 Cr single-cheque capacity.
Wealth-channel distribution (ALTPORT listing): retailising the LP base beyond institutions.
Warrant discipline: equity kickers (Spinny 28x) as the return engine above coupon.
What can break
Unverified claims meet visible casualties: Dunzo and BluSmart resolutions, if negative, retroactively reprice the <0.5% story.
The 'Fund IV' distributor listing without disclosure is exactly the opacity pattern institutional LPs punish.
EV exposure concentration (Ola Electric, Ather, BluSmart, Euler) ties the book to one policy-dependent sector's cash cycles.
Fund IV / 'India Fund I': distributor listing only; verify existence, size, regulator filings.
SDS final close (~$100M target).
Dunzo and BluSmart recovery outcomes: both undisclosed.
Point-in-time discipline: these are the open items we could not verify at the current vintage. They get resolved: confirmed, corrected or dropped, at the next monthly refresh, never silently.
The takes · one screen, three readers
Ask for three numbers nobody has published: Dunzo recovery, BluSmart exposure, and Fund IV's actual terms. The ~130% Fund I DPI claim is diligence-able: make them show the distribution schedule.
Alteria's SDS quietly competes with your portfolio companies' banks, not with you. Its borrower list doubles as a solvency screen: names taking ₹100 Cr+ debt tranches are choosing runway over repricing.
Alteria + Trifecta + Stride all co-lending Euler Motors in one round (Mar 2026) is the tell: EV working capital is now a syndicated asset class. Cross-read with our EV & Climate exposure data.
Sourcing. Every figure is sourced and dated. We tier provenance: Primary (official, regulatory, exchange or company filings), Secondary (tier-1 industry research and reputable media), and GW estimate (our own reconstruction or opinion, labelled, never presented as external fact). We prefer primary where it exists, reconcile divergent prints to cited ranges, and hold every number point-in-time: dated, and never silently restated; revisions publish as dated changes.
Fact vs opinion. Facts vs opinion: market sizes, official prints, prices, named deals and agency ratings are sourced facts (Primary/Secondary). Scores, grades, purity weights, scenario paths and indicative sparkline points are Gravitywell's analytical opinion (GW estimate): labelled, not presented as external data.
GW GP Scores are research opinions, not investment advice, not a solicitation, and not an assessment under any SEBI regulation. Dossiers are compiled from public sources believed reliable; firms named did not participate and figures marked E are Gravitywell estimates. Point-in-time: dated to the vintage shown and never silently restated.